Galera Therapeutics, Inc. (GRTX)

CIK 1563577 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Galera Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G/A0001193125-26-352953
Aug 7, 2026EFFECT9999999995-26-002579
Aug 5, 202640001193125-26-335178
Aug 5, 202640001193125-26-335499
Aug 5, 202640001193125-26-335228
Aug 5, 202640001193125-26-335196
Aug 5, 202640001193125-26-335224
Aug 5, 202640001193125-26-335215
Aug 4, 20268-K0001193125-26-331207
Aug 4, 2026POS AM0001193125-26-332796
Aug 4, 2026S-8 POS0001193125-26-332791
Aug 4, 2026S-8 POS0001193125-26-332786
Aug 4, 202615-12G0001193125-26-332816
Jul 31, 20268-K0001193125-26-328716
Jul 13, 2026DEFA14C0001193125-26-302005
Jul 13, 20268-K0001193125-26-301997
Jul 7, 20268-K0001193125-26-296981
Jul 7, 2026DEFA14C0001193125-26-296982
Jul 2, 2026DEFM14C0001193125-26-294765
Jun 11, 2026SCHEDULE 13D0001104659-26-073025
Jun 2, 20264250001193125-26-253624
Jun 2, 20264250001193125-26-253623
May 29, 2026SCHEDULE 13D/A0001123292-26-000773
May 29, 202640001123292-26-000772
May 22, 20264250001193125-26-235217